Nova Eye Medical Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Tom Spurling
Chief executive officer
AU$291.1k
Total compensation
CEO salary percentage | 84.3% |
CEO tenure | 4.3yrs |
CEO ownership | 0.4% |
Management average tenure | 6.2yrs |
Board average tenure | 6.3yrs |
Recent management updates
Recent updates
Nova Eye Medical Limited (ASX:EYE) Might Not Be As Mispriced As It Looks After Plunging 26%
Sep 22Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)
Aug 06Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward
Apr 18Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?
Mar 26News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts
Jan 19Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce
Dec 27We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate
Sep 03Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified
Apr 17Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?
Dec 16We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully
Aug 27CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | AU$291k | AU$245k | -AU$9m |
Mar 31 2024 | n/a | n/a | -AU$12m |
Dec 31 2023 | n/a | n/a | -AU$14m |
Sep 30 2023 | n/a | n/a | -AU$15m |
Jun 30 2023 | AU$253k | AU$211k | -AU$15m |
Mar 31 2023 | n/a | n/a | -AU$13m |
Dec 31 2022 | n/a | n/a | -AU$11m |
Sep 30 2022 | n/a | n/a | -AU$9m |
Jun 30 2022 | AU$311k | AU$191k | -AU$7m |
Mar 31 2022 | n/a | n/a | -AU$7m |
Dec 31 2021 | n/a | n/a | -AU$6m |
Sep 30 2021 | n/a | n/a | -AU$5m |
Jun 30 2021 | AU$72k | AU$66k | -AU$4m |
Dec 31 2020 | n/a | n/a | -AU$9m |
Sep 30 2020 | n/a | n/a | -AU$10m |
Jun 30 2020 | n/a | n/a | -AU$10m |
Dec 31 2019 | n/a | n/a | -AU$6m |
Sep 30 2019 | n/a | n/a | -AU$6m |
Jun 30 2019 | AU$328k | AU$306k | -AU$7m |
Mar 31 2019 | n/a | n/a | -AU$7m |
Dec 31 2018 | n/a | n/a | -AU$6m |
Sep 30 2018 | n/a | n/a | -AU$6m |
Jun 30 2018 | AU$329k | AU$300k | -AU$5m |
Compensation vs Market: Tom's total compensation ($USD191.17K) is below average for companies of similar size in the Australian market ($USD299.41K).
Compensation vs Earnings: Tom's compensation has increased whilst the company is unprofitable.
CEO
Tom Spurling (62 yo)
4.3yrs
Tenure
AU$291,117
Compensation
Mr. Thomas H. Spurling, also known as Tom, BSc (Hons), Ph D., FRACI, FTSE, AM is an Executive Director at Nova Eye Medical Limited since August 31, 2020 and serves as its Managing Director. Mr. Spurling wa...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder & Executive Chairman | 23.3yrs | AU$254.51k | no data | |
MD & Executive Director | no data | AU$291.12k | 0.37% A$ 139.5k | |
Chief Financial Officer | no data | no data | no data | |
Investor Relations | no data | no data | no data | |
Chief Commercial Officer | no data | no data | no data | |
Chief Medical Officer | 6.1yrs | no data | no data | |
President of Ellex iTrack | 6.3yrs | no data | no data | |
Company Secretary | 4.4yrs | no data | no data | |
Vice President of Global Service | no data | AU$143.97k | no data | |
Advisor to the Board | no data | AU$243.97k | no data |
6.2yrs
Average Tenure
66yo
Average Age
Experienced Management: EYE's management team is seasoned and experienced (6.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder & Executive Chairman | 23.3yrs | AU$254.51k | no data | |
MD & Executive Director | 4.3yrs | AU$291.12k | 0.37% A$ 139.5k | |
Independent Director | 11.5yrs | AU$55.50k | 0.59% A$ 221.3k | |
Non Executive Director | 6.3yrs | AU$61.05k | 0.0087% A$ 3.3k | |
Independent Director | 2yrs | AU$61.05k | 0.24% A$ 91.7k |
6.3yrs
Average Tenure
62yo
Average Age
Experienced Board: EYE's board of directors are considered experienced (6.3 years average tenure).